UBS Downgrades St. Jude Medical (STJ) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Tech stocks bolster Wall Street as Nvidia quells AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil rises by over $1 as White House says no US-Iran talks happening
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
- First Financial to acquire Hickory Point Bank in $111.3M deal
Barclays Upgrades St. Jude Medical (STJ) to Equalweight
May 11, 2016 6:52 AM EDTBarclays upgraded St. Jude Medical (NYSE: STJ) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $75.51 yesterday.
... MoreSunTrust Robinson Humphrey Downgrades St. Jude Medical (STJ) to Neutral
May 10, 2016 7:04 AM EDTSunTrust Robinson Humphrey downgraded St. Jude Medical (NYSE: STJ) from Buy to Neutral with a price target of $80.00 (from $70.00).
For an analyst ratings summary and ratings history on St. Jude Medical... More
